Loading...
Tumor-infiltrating lymphocytes in melanoma
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective treatment for patients with metastatic melanoma. With higher response rates than ipilimumab or IL-2, and longer durations of response than vemurafenib, TIL therapy carries the potential to transform curre...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3462483/ https://ncbi.nlm.nih.gov/pubmed/22878966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-012-0257-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|